2 Strong Buy Stocks From Our Top-Performing Portfolio

By Mijuško Šibalić, Stock Market Writer and Stock Researcher
January 7, 2026 6:17 AM UTC
2 Strong Buy Stocks From Our Top-Performing Portfolio

On the whole, 2025 was a great year for the stock market. The benchmark S&P 500 index posted a return of 17.9% for the year, marking the third consecutive year of double-digit gains.

The lion’s share of these gains was driven by big tech and artificial intelligence companies — and despite both posting promising gains since the start of the new year, valuation concerns remain present.

Here’s the thing. AI isn’t just a dominant narrative, but can also serve as a powerful research tool. In uncertain times like these, the ability to process vast amounts of data and turn it into actionable intel can be a game-changer. 

As time goes on, that ability will turn from what it is now — a definite edge, into a regular part of the stock researcher’s toolkit. Right now, it’s an advantage — tomorrow, those who fail to adapt will be left playing catch-up. The conclusion is simple — integrating these capabilities into your approach to investing as soon as possible is the best course of action.

But it’s hard not to note an abundance of promises and relatively lackluster results — anywhere you look, there’s a ton of low-effort AI products, and it’s no different in the world of stock research.

So, what should you do? You should find a proven paradigm — something that’s both easy to use and has a proven track record. Well, congratulations — you’ve found it — all you have to do is turn to our…

AI Factor Stock Strategy

Our quant rating system uses 115 unique factors, split across 7 categories, to evaluate roughly 4,600 stocks every single day. Those insights are boiled down to a single metric — a stock’s Zen Rating.

A Zen Rating of A is equivalent to a Strong Buy rating, and is only given to the top 5% of stocks. That’s a great start, but it does still leave roughly 230 equities to consider on any given day. However, you can narrow down the search by turning to our Zen Strategies.

These are 11 exclusive portfolios, and each consists of just 7 rigorously-selected stocks. 

So, remember how we talked about AI in the beginning? Each Zen Rating is a composite score derived from 7 Component Grade ratings — and one of those ratings is Artificial Intelligence. In essence, it uses a neural network trained on two decades of market data to identify likely outperformers. Better yet, since it’s constantly receiving updates, it’s only going to get better as time goes on.

That AI rating is at the core of our top-performing strategy, which has an all-time annual return of 47.7%. It has outperformed the S&P 500 by double digits in 13 of the last 19 years. Today, we’ll be taking a look at two exciting stocks from our AI Factor Stock Strategy.

Aveanna Healthcare (AVAH)

Our first pick, Aveanna Healthcare, is a diversified home health care provider with a $1.69 billion market cap. At present, AVAH ranks in the top 1% of the stocks that we track, and ranks 26th overall, placing firmly among the cream of the crop even among other A-rated stocks.

Aveanna Healthcare is the 3rd highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of A. On top of that, it has Wall Street’s seal of approval — based on 8 analysts who offer price targets for the stock, the average 12-month price forecast sits at $10.19, and implies a 26.09% upside. This puts AVAH in the top 3% of stocks for Sentiment.

What about the Artificial Intelligence Component Grade rating? Here, Aveanna Healthcare is in the top 15%. To cap everything off, the stock ranks in the 82nd percentile for Value and the 92nd percentile for Growth. Right now, it’s trading at a P/E of 21.26x and a PEG of 0.42x, while earnings are forecast to grow at a rate of 62.92% per year, almost twice the industry average.

Wanna know the best part? You can buy the dip on AVAH right now — the stock has dropped by 6.26% in the last 7 days. The company has beaten earnings estimates for the last 3 quarters in a row — so a growth trajectory, while young, is present.

Betterware De Mexico (BWMX)

Betterware is a direct-to-consumer specialty retailer. This $590 million market cap stock ranks in the top 1% of the equities that we track — to be more precise, it’s currently rated 2nd overall out of 4,600, so you almost literally can’t get better than this.

Just like with our previous entry, we have a compelling mix of Value and Growth — the stock is in the top 9% for the former, and the 83rd percentile for the latter. With an average price target of $21.67, which implies a 36.87% upside, BWMX also ranks in the top 10% for Sentiment.

In fact, most of Betterware’s Component Grade ratings are quite impressive. BWMX is in the top 5% for Financials, the top 10% for Safety, and the 97th percentile for Artificial Intelligence.

BWMX also ranks in the top 10% for Momentum, owing to a 43.26% rally over the past 365 days. There’s a strong undercurrent of enthusiasm here — although it has beaten estimates in the past two quarters, it missed them in the two before that — but the upward trajectory hasn’t ceased. Right now, it’s quite appealing, particularly since it ranks so highly for both Value and Growth —the company’s next earnings call, due February 19, could provide additional fuel for the ongoing surge.

Interested In More Great Stock Picks?

The 2 stocks highlighted above are just a fraction of what you get from our proven AI Factor Stock strategy

That’s because each day our system recalibrates — and Zen Strategies members get access to the top 7 income stocks based on 115 different parameters that point to outperformance. 

See all Top 7 AI Factor stocks here >

However, maybe you’re not a fan of AI-derived insights. Perhaps you would like to see all 11 of our market beating strategies including Growth, Value, Momentum or perhaps even Income stocks. 

Each featuring the top 7 stocks.

Each featuring tremendous performance.

We spell it all out in this timely presentation below that lives up to its name:

77 Best Stocks Now! > 

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.